XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder

By: via Benzinga
XenoPort (NASDAQ: XNPT) today reported an update on prescription trends and further development of HORIZANT Extended-Release Tablets, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.